CVE-2016-5819

Description

Moxa G3100V2 Series, editions prior to Version 2.8, and OnCell G3111/G3151/G3211/G3251 Series, editions prior to Version 1.7 allows a reflected cross-site scripting attack which may allow an attacker to execute arbitrary script code in the user’s browser within the trust relationship between their browser and the server.

Category

6.1
CVSS
Severity: Medium
CVSS 3.0 •
CVSS 2.0 •
EPSS 0.18%
Third-Party Advisory us-cert.gov
Affected: Moxa OnCell G3100V2 Series
Affected: Moxa OnCell G3111/G3151/G3211/G3251 Series
Published at:
Updated at:

References

Link Tags
https://ics-cert.us-cert.gov/advisories/ICSA-16-236-01 third party advisory us government resource

Frequently Asked Questions

What is the severity of CVE-2016-5819?
CVE-2016-5819 has been scored as a medium severity vulnerability.
How to fix CVE-2016-5819?
To fix CVE-2016-5819, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2016-5819 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2016-5819 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2016-5819?
CVE-2016-5819 affects Moxa OnCell G3100V2 Series, Moxa OnCell G3111/G3151/G3211/G3251 Series.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.